RAF plus EGFR Inhibition for BRAF-Mutant Metastatic Colorectal Cancer-Letter.
University of California, San Diego, California. ssorscher@ucsd.edu.
Steven
S
Sorscher
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008297:Male; D048493:Proto-Oncogene Proteins B-raf / Q000037:antagonists & inhibitors*; D013449:Sulfonamides / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D007211:Indoles; D013449:Sulfonamides; D066246:ErbB Receptors; D048493:Proto-Oncogene Proteins B-raf